Back to Journals » Journal of Hepatocellular Carcinoma

Impact Factor

Journal of Hepatocellular Carcinoma

ISSN: 2253-5969

Journal Articles:

- 625 records -

Review

Research Progress in Predicting Hepatocellular Carcinoma with Portal Vein Tumour Thrombus in the Era of Artificial Intelligence

Li Y, Fan N, He X, Zhu J, Zhang J, Lu L

Journal of Hepatocellular Carcinoma 2024, 11:1429-1438

Published Date: 17 July 2024

Original Research

Hepatic Arterial Infusion Chemotherapy Combined with Lenvatinib and PD-1 Inhibitors for Managing Arterioportal Shunt in Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Retrospective Cohort Study

Liu G, Zhu D, He Q, Zhou C, He L, Li Z, Jiang Z, Huang M, Chang B, Wu C

Journal of Hepatocellular Carcinoma 2024, 11:1415-1428

Published Date: 12 July 2024

Original Research

A Simple Prognostic Scoring System for Hepatocellular Carcinoma Treated with DEB-TACE

Jiang B, Lu D, Dai J, Li K, Du Q, Xie B, Xie J, Zhu X, Xie X

Journal of Hepatocellular Carcinoma 2024, 11:1403-1414

Published Date: 10 July 2024

Original Research

Portal Venous and Hepatic Arterial Coefficients Predict Post-Hepatectomy Overall and Recurrence-Free Survival in Patients with Hepatocellular Carcinoma: A Retrospective Study

Li YK, Wu S, Wu YS, Zhang WH, Wang Y, Li YH, Kang Q, Huang SQ, Zheng K, Jiang GM, Wang QB, Liang YB, Li J, Lakang Y, Yang C, Li J, Wang JP, Kui X, Ke Y

Journal of Hepatocellular Carcinoma 2024, 11:1389-1402

Published Date: 9 July 2024

Original Research

Recurrence of Hepatocellular Carcinoma in Patients with Low Albumin-Bilirubin Grade in TACE Combined with Ablation: A Random Forest Cox Predictive Model

Xiong Y, Qiao W, Mei T, Li K, Jin R, Zhang Y

Journal of Hepatocellular Carcinoma 2024, 11:1375-1388

Published Date: 8 July 2024

Original Research

CD276 Promotes an Inhibitory Tumor Microenvironment in Hepatocellular Carcinoma and is Associated with Poor Prognosis

Liu WF, Jiang QY, Qi ZR, Zhang F, Tang WQ, Wang HQ, Dong L

Journal of Hepatocellular Carcinoma 2024, 11:1357-1373

Published Date: 9 July 2024

Original Research

New HCC Subtypes Based on CD8 Tex-Related lncRNA Signature Could Predict Prognosis, Immunological and Drug Sensitivity Characteristics of Hepatocellular Carcinoma

Ge J, Tao M, Zhang G, Cai J, Li D, Tao L

Journal of Hepatocellular Carcinoma 2024, 11:1331-1355

Published Date: 5 July 2024

Original Research

Utility of Machine Learning in the Prediction of Post-Hepatectomy Liver Failure in Liver Cancer

Tashiro H, Onoe T, Tanimine N, Tazuma S, Shibata Y, Sudo T, Sada H, Shimada N, Tazawa H, Suzuki T, Shimizu Y

Journal of Hepatocellular Carcinoma 2024, 11:1323-1330

Published Date: 5 July 2024

Original Research

The Impact of Proton Pump Inhibitors on the Efficacy of Immune Checkpoint Inhibitor Combinations in Patients with HBV-Associated Advanced Hepatocellular Carcinoma

Wang N, Xu Y, Yang G, Chen H, Wang X, Fu J, Li L, Pan X

Journal of Hepatocellular Carcinoma 2024, 11:1311-1321

Published Date: 4 July 2024

Original Research

IL-6 Released from Hepatic Stellate Cells Promotes Glycolysis and Migration of HCC Through the JAK1/vWF/TGFB1 Axis

Zhu Y, Gu J, Lu Y, Tao Q, Cao X, Zhu Y, Yang MQ, Liang X

Journal of Hepatocellular Carcinoma 2024, 11:1295-1310

Published Date: 5 July 2024

Original Research

Decision-Tree Models Indicative of Microvascular Invasion on MRI Predict Survival in Patients with Hepatocellular Carcinoma Following Tumor Ablation

Schmidt R, Hamm CA, Rueger C, Xu H, He Y, Gottwald LA, Gebauer B, Savic LJ

Journal of Hepatocellular Carcinoma 2024, 11:1279-1293

Published Date: 3 July 2024

Review

Breaking the Barriers of Therapy Resistance: Harnessing Ferroptosis for Effective Hepatocellular Carcinoma Therapy

Lv X, Lan G, Zhu L, Guo Q

Journal of Hepatocellular Carcinoma 2024, 11:1265-1278

Published Date: 2 July 2024

Original Research

Prognostic Value of Alpha-Fetoprotein in Unresectable Hepatocellular Carcinoma Treated with Hepatic Artery Infusion Chemotherapy Combined with Lenvatinib and Camrelizumab

Xiao Y, Chen W, Deng W, Zhu G, Xie J, Luo L, Lin L, Tao J, Hu Z, Shan R

Journal of Hepatocellular Carcinoma 2024, 11:1251-1263

Published Date: 2 July 2024

Original Research

Limited Generalizability of Retrospective Single-Center Cohort Study in Comparison to Multicenter Cohort Study on Prognosis of Hepatocellular Carcinoma

Kim YR, Chung SW, Kim MJ, Choi WM, Choi J, Lee D, Lee HC, Shim JH

Journal of Hepatocellular Carcinoma 2024, 11:1235-1249

Published Date: 1 July 2024

Original Research

The Potential of the lncRNAs ADAMTSL4-AS1, AC067931 and SOCS2-AS1 in Peripheral Blood Mononuclear Cells as Novel Diagnostic Biomarkers for Hepatitis B Virus-Associated Hepatocellular Carcinoma

Guan W, Zhang C, Miao T, Dong C, Li L, Yuan X, Zhao D, Ai R, Zhang X, Sun M, Kang H, Nan Y

Journal of Hepatocellular Carcinoma 2024, 11:1221-1233

Published Date: 27 June 2024

Original Research

Efficacy and Safety Analysis of Transarterial Chemoembolization Plus Donafenib With or Without Immune Checkpoint Inhibitors for Unresectable Hepatocellular Carcinoma: A Prospective, Single-Arm, Single-Center, Phase II Clinical Study

Li J, Li Y, Song J, Zhao L

Journal of Hepatocellular Carcinoma 2024, 11:1207-1219

Published Date: 27 June 2024

Original Research

The Influence of Visceral Adiposity on Overall Survival: Exploring “Obesity Paradox” Among Hepatocellular Carcinoma Patients Who Receiving Immunotherapy

Zhou Y, Ouyang J, Yang H, Wang Z, Yang Y, Li Q, Zhao H, Zhou J, Li Q

Journal of Hepatocellular Carcinoma 2024, 11:1193-1206

Published Date: 24 June 2024

Original Research

Radiomics-Based Prediction of Microvascular Invasion Grade in Nodular Hepatocellular Carcinoma Using Contrast-Enhanced Magnetic Resonance Imaging

Zhang Z, Jia XF, Chen XY, Chen YH, Pan KH

Journal of Hepatocellular Carcinoma 2024, 11:1185-1192

Published Date: 21 June 2024

Review

GDF15: Immunomodulatory Role in Hepatocellular Carcinoma Pathogenesis and Therapeutic Implications

Du YN, Zhao JW

Journal of Hepatocellular Carcinoma 2024, 11:1171-1183

Published Date: 19 June 2024

Original Research

PD-1 Inhibitors Combined with Tyrosine Kinase Inhibitors with or without Hepatic Artery Infusion Chemotherapy for the First-Line Treatment of HBV-Related Advanced Hepatocellular Carcinoma: A Retrospective Study

Wang D, Zhang Z, Yang L, Zhao L, Liu Z, Lou C

Journal of Hepatocellular Carcinoma 2024, 11:1157-1170

Published Date: 18 June 2024

Review

Research Progress on the Role of Epigenetic Methylation Modification in Hepatocellular Carcinoma

Wang J, Gao W, Yu H, Xu Y, Bai C, Cong Q, Zhu Y

Journal of Hepatocellular Carcinoma 2024, 11:1143-1156

Published Date: 17 June 2024

Original Research

Establishing and Externally Validating a Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) Score-Based Nomogram for Predicting Early Recurrence in BCLC Stage 0/A Hepatocellular Carcinoma Patients After Radical Liver Resection: A Multi-Center Study

Liu X, Qiu Z, Ndhlovu E, Wan Y, Sun H, Wang S, Cao Y, Zhu P

Journal of Hepatocellular Carcinoma 2024, 11:1127-1141

Published Date: 14 June 2024

Original Research

Incorporating Inflammatory Markers and Clinical Indicators into a Predictive Model of Single Small Hepatocellular Carcinoma Recurrence After Primary Locoregional Treatments

Qiao W, Xiong Y, Li K, Jin R, Zhang Y

Journal of Hepatocellular Carcinoma 2024, 11:1113-1125

Published Date: 13 June 2024

Original Research

Circ_0007386 Promotes the Progression of Hepatocellular Carcinoma Through the miR-507/ CCNT2 Axis

Feng Y, Liang L, Jia W, Wang J, Xu C, Zhu D, Xu B, Zhao W, Ling X, Zhou Y, Kong L, Ding W

Journal of Hepatocellular Carcinoma 2024, 11:1095-1112

Published Date: 13 June 2024

Original Research

Transarterial Chemoembolization Combined with Atezolizumab Plus Bevacizumab versus Transarterial Chemoembolization Alone in Intermediate‐stage Hepatocellular Carcinoma: A Multicenter Retrospective Study

Zheng Y, Xiang Y, Shi H, Lin Z, Cheng S, Zhu J

Journal of Hepatocellular Carcinoma 2024, 11:1079-1093

Published Date: 12 June 2024

Original Research

Efficacy and Safety of Transarterial Chemoembolization and Repeated Partial Splenic Embolization for Hepatocellular Carcinoma with Hypersplenism and Thrombocytopenia

Hong W, Wang Z, Yao W, Zhang X, Zhang L, Liang B

Journal of Hepatocellular Carcinoma 2024, 11:1065-1078

Published Date: 11 June 2024

Original Research

Development and Validation of a Novel Prognostic Nomogram Based on Platelet and CD8+T Cell Counts in Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombosis

Shi W, Yan H, Liu X, Yu L, Xie Y, Wu Y, Liang Y, Yang Z

Journal of Hepatocellular Carcinoma 2024, 11:1049-1063

Published Date: 7 June 2024

Original Research

LAYN Serves as a Prognostic Biomarker and Downregulates Tumor-Infiltrating CD8+ T Cell Function in Hepatocellular Carcinoma

Xiao S, Lu L, Lin Z, Ye X, Su S, Zhang C, You Y, Li W, Huang X, Wu W, Zhou Y

Journal of Hepatocellular Carcinoma 2024, 11:1031-1048

Published Date: 6 June 2024

Original Research

Changes in Posttreatment Spleen Volume Associated with Immunotherapy Outcomes for Advanced Hepatocellular Carcinoma

Chen BB, Liang PC, Shih TTF, Liu TH, Shen YC, Lu LC, Lin ZZ, Hsu C, Hsu CH, Cheng AL, Shao YY

Journal of Hepatocellular Carcinoma 2024, 11:1015-1029

Published Date: 5 June 2024

Case report

Prolonged Complete Remission Using Tislelizumab for Hepatocellular Carcinoma After Adjuvant Chemotherapy Failure: A Case Report

Zhu X, Dong S, Tang J, Xie R, Wu H, Guan J, Hu S

Journal of Hepatocellular Carcinoma 2024, 11:1005-1013

Published Date: 4 June 2024

Rapid Communication

A Comparison of Presentation, Treatment, and Survival After Hepatocellular Carcinoma of Viral and Non-Viral Etiology in Damietta, Egypt, 2007–2019

Jean K, Tawheed A, Luong Nguyen LB, Heikal T, Eldaly U, Elhadidy NG, Elghaieb A, Aboudonia A, Tondeur L, Dublineau A, Fontanet A, El-Kassas M

Journal of Hepatocellular Carcinoma 2024, 11:997-1004

Published Date: 31 May 2024

Review

CRISPR in Targeted Therapy and Adoptive T Cell Immunotherapy for Hepatocellular Carcinoma

Palaz F, Ozsoz M, Zarrinpar A, Sahin I

Journal of Hepatocellular Carcinoma 2024, 11:975-995

Published Date: 30 May 2024

Expert Opinion

A Post-International Gastrointestinal Cancers’ Conference (IGICC) Position Statements

Yalcin S, Lacin S, Kaseb AO, Peynircioğlu B, Cantasdemir M, Çil BE, Hurmuz P, Doğrul AB, Bozkurt MF, Abali H, Akhan O, Şimşek H, Sahin B, Aykan FN, Yücel İ, Tellioğlu G, Selçukbiricik F, Philip PA

Journal of Hepatocellular Carcinoma 2024, 11:953-974

Published Date: 29 May 2024

Original Research

Prediction of Microvascular Invasion and Recurrence After Curative Resection of LI-RADS Category 5 Hepatocellular Carcinoma on Gd-BOPTA Enhanced MRI

Zhang J, Li Y, Xia J, Pan X, Lu L, Fu J, Jia N

Journal of Hepatocellular Carcinoma 2024, 11:941-952

Published Date: 25 May 2024

Original Research

Preoperative Antiviral Therapy and Long-Term Outcomes for Hepatitis B Virus-Related Hepatocellular Carcinoma After Curative Liver Resection: A Multicenter Analysis

Dai MG, Liu SY, Zhu L, Lu WF, Xie GL, Liang L, Liu JW, Ye B

Journal of Hepatocellular Carcinoma 2024, 11:927-939

Published Date: 23 May 2024

Original Research

A Novel Nomogram to Predict Prognosis of Advanced Hepatocellular Carcinoma Treated with Intensity-Modulated Radiotherapy Plus Anti-PD1

He M, Liang C, Pang Y, Jiang M, Long M, Yao Z, Wang X, Zhang R, Wu Q, Liang S, Li J

Journal of Hepatocellular Carcinoma 2024, 11:913-925

Published Date: 22 May 2024

Original Research

A Novel Nomogram to Predict Prognosis in Elderly Early-Stage Hepatocellular Carcinoma Patients After Ablation Therapy

Tang X, Wang Q, Jin R, Hu C

Journal of Hepatocellular Carcinoma 2024, 11:901-911

Published Date: 17 May 2024

Original Research

Integration of Single-Cell RNA Sequencing and Bulk RNA Sequencing to Identify an Immunogenic Cell Death-Related 5-Gene Prognostic Signature in Hepatocellular Carcinoma

Peng L, Xu S, Xu JL

Journal of Hepatocellular Carcinoma 2024, 11:879-900

Published Date: 16 May 2024

Original Research

Construction of a Prognostic Model for Hepatocellular Carcinoma Based on Macrophage Polarization-Related Genes

Chen H, Li J, Cao D, Tang H

Journal of Hepatocellular Carcinoma 2024, 11:857-878

Published Date: 11 May 2024

Original Research

Mechanisms of Sorafenib Resistance in HCC Culture Relate to the Impaired Membrane Expression of Organic Cation Transporter 1 (OCT1)

Chava S, Ekmen N, Ferraris P, Aydin Y, Moroz K, Wu T, Thung SN, Dash S

Journal of Hepatocellular Carcinoma 2024, 11:839-855

Published Date: 9 May 2024

Original Research

PVALB Was Identified as an Independent Prognostic Factor for HCC Closely Related to Immunity, and Its Absence Accelerates Tumor Progression by Regulating NK Cell Infiltration

Gong Y, Zhou M, Zhu Y, Pan J, Zhou X, Jiang Y, Zeng H, Zheng H, Geng X, Huang D

Journal of Hepatocellular Carcinoma 2024, 11:813-838

Published Date: 8 May 2024

Original Research

Patterns, Risk Factors, and Outcomes of Recurrence After Hepatectomy for Hepatocellular Carcinoma with and without Microvascular Invasion

Yu Y, Wang XH, Hu WJ, Chen DH, Hu ZL, Li SQ

Journal of Hepatocellular Carcinoma 2024, 11:801-812

Published Date: 8 May 2024

Original Research

CXCL9 Overexpression Predicts Better HCC Response to Anti-PD-1 Therapy and Promotes N1 Polarization of Neutrophils

Wang P, Xu MH, Xu WX, Dong ZY, Shen YH, Qin WZ

Journal of Hepatocellular Carcinoma 2024, 11:787-800

Published Date: 8 May 2024

Original Research

A Modified Targetoid Feature Emphasizing Thin-Rim APHE to Improve the Diagnostic Performance of LI-RADS for Malignant Hepatic Tumors

Huang R, Zheng C, Xu G, Chen X, Shen J, Mao S

Journal of Hepatocellular Carcinoma 2024, 11:775-786

Published Date: 26 April 2024

Original Research

Clinical Characteristics of Non-B and Non-C Biopsy-Proven Primary Liver Cancers in an HBV- Endemic Area: A Retrospective Study

Hu Z, Zhou H

Journal of Hepatocellular Carcinoma 2024, 11:767-774

Published Date: 24 April 2024

Original Research

A Novel Four-Gene Signature Based on Nonsense-Mediated RNA Decay for Predicting Prognosis in Hepatocellular Carcinoma: Bioinformatics Analysis and Functional Validation

Zhao J, Wang C, Zhao L, Zhou H, Wu R, Zhang T, Ding J, Zhou J, Zheng H, Zhang L, Kong T, Zhou J, Hu Z

Journal of Hepatocellular Carcinoma 2024, 11:747-766

Published Date: 23 April 2024

Original Research

Triglyceride-Glucose Index is an Independent Risk Factor for Hepatocellular Carcinoma Development in Patients with HBV-Related Liver Cirrhosis

Yang SH, He YS, Zheng SQ, Zhang XJ, Dai H, Xue Y

Journal of Hepatocellular Carcinoma 2024, 11:737-746

Published Date: 18 April 2024

Original Research

Adjuvant Transarterial Chemoembolization Plus Immunotherapy for Huge Hepatocellular Carcinoma: A Propensity Score Matching Cohort Study

Huang H, Liao W, Zhang K, Wang H, Cheng Q, Mei B

Journal of Hepatocellular Carcinoma 2024, 11:721-735

Published Date: 8 April 2024

Review

Macroscopic Characterization of Hepatocellular Carcinoma: An Underexploited Source of Prognostic Factors

Gonvers S, Martins-Filho SN, Hirayama A, Calderaro J, Phillips R, Uldry E, Demartines N, Melloul E, Park YN, Paradis V, Thung SN, Alves V, Sempoux C, Labgaa I

Journal of Hepatocellular Carcinoma 2024, 11:707-719

Published Date: 6 April 2024

Original Research

Development and Validation of a Nomogram for Patients Undergoing Transarterial Chemoembolization for Recurrent Hepatocellular Carcinoma After Hepatectomy

Xie D, Li Z, Yuan J, Yin X, Chen R, Zhang L, Ren Z

Journal of Hepatocellular Carcinoma 2024, 11:693-705

Published Date: 4 April 2024